MedTrace Logo

Tailored Screening for Breast Cancer in Premenopausal Women

NCT02619123 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33200

Last updated 2017-02-10

No results posted yet for this study

Summary

The Tailored Breast Screening Trial (TBST) is a population-based, non-inferiority randomised trial aimed at evaluating the impact of tailored screening strategies addressed to premenopausal women, by using breast density as indicator of risk.

44-45 years old women will be enrolled and invited to undergo a digital mammography. Women are then randomly allocated in two arms. In the intervention arm, women will receive a tailored screening strategy according to breast density.

The aim of this study is to assess the impact of a longer screening interval and the reduction of side effects for premenopausal women.

Conditions

Interventions

OTHER

Tailored screening according to breast density

Different interval of mammography screening according to breast density

OTHER

Annual invitation to mammography

Annual interval mammography screening according to international guidelines for women younger than 50 years old

Sponsors & Collaborators

  • Ministry of Health, Italy

    collaborator OTHER_GOV

  • Cancer Prevention and Research Institute, Italy

    lead OTHER

Principal Investigators

  • Paola Mantellini, MD · Cancer Prevention and Research Institute, ISPO

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
44 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2020-01-31
Completion
2022-01-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02619123 on ClinicalTrials.gov